Month: May 2024

Last patient last visit in randomized, double-blind, SIGNAL-AD Phase 2a study of pepinemab treatment for Alzheimer’s Disease is scheduled for early June 2024 ROCHESTER, N.Y., May 15, 2024 (GLOBE NEWSWIRE) — Vaccinex, Inc. (Nasdaq: VCNX), a clinical-stage biotechnology company pioneering a differentiated approach to treating neurodegenerative disease and cancer through the inhibition of Semaphorin 4D (SEMA4D), today announced financial results for the first quarter ended March 31, 2024, and provided a corporate update on its key program for Alzheimer’s disease. Treatment with pepinemab believed to halt or slow progression of neurodegenerative disease: Vaccinex expects to complete the planned 12-months of treatment of the last patients enrolled in its randomized, double-blind, Phase 2a SIGNAL-AD trial of pepinemab anti-SEMA4D antibody...

SHANGHAI, China, May 15, 2024 (GLOBE NEWSWIRE) — Dada Nexus Limited (NASDAQ: DADA, “Dada”, the “Company”, or “we”), China’s leading local on-demand retail and delivery platform, today announced its unaudited financial results for the first quarter ended March 31, 2024. “We are pleased to announce that our on-demand retail service has been upgraded to JD NOW, aiming to bring quality goods to consumers at top-notch speeds. With the introduction of the new brand, we have entered a new chapter with a focus on building a sustainable ecosystem,” said Mr. Bing Fu, Interim President of Dada, “For JD NOW, we are determined to fully embrace the JD.com ecosystem in a customer-centric approach and are making dedicated investments to improve customer experience, including rolling out delivery fee waiver program and further lowering the free...

VANCOUVER, British Columbia, May 15, 2024 (GLOBE NEWSWIRE) — Euro Manganese Inc. (TSX-V and ASX: EMN; OTCQB: EUMNF; Frankfurt: E06) (the “Company” or “EMN”) today announced financial results and key developments during the second fiscal quarter and to date. The Company has now filed its March 31, 2024, second fiscal quarter Financial Statements and Management’s Discussion and Analysis. Euro Manganese’s fiscal year end is September 30. Key Developments During and Subsequent to the QuarterChvaletice Project, Czech RepublicChvaletice Manganese Project (“Chvaletice Project” or the “Project”) was formally listed as under appraisal for debt financing with the European Investment Bank (“EIB”). Funding from the EIB would complement a broader funding package to support the...

SEATTLE, May 15, 2024 (GLOBE NEWSWIRE) — Banzai International, Inc. (NASDAQ: BNZI) (“Banzai” or the “Company”), a leading SaaS marketing technology company, today reported financial results for the first quarter ended March 31, 2024. First Quarter 2024 Financial Summary and Recent Operational HighlightsAnnual Recurring Revenue (“ARR”) for March 2024 was $4.9 million, a 14.2% increase compared to Q4 2023, and a 5% increase year-over-year. Revenue of $1.1 million exceeded the operating forecast as of the previous quarter by 4%. Net Income increased sequentially by $1.9 million, a 30% increase from Q4 2023. The Company added over 230 customers in April, bringing the total number of customer wins and reactivations during the first four months of 2024 to 810. Banzai unveiled Reach 2.0, a major milestone release of the Company’s flagship...

First Quarter 2024 vs. First Quarter 2023Revenue of $19.1 million compared to $22.0 million; Gross profit of $3.6 million compared to $4.7 million; Gross profit margin of 18.6% compared to 21.2%; Net income of $0.2 million compared to $1.0 million; Earnings per share of $0.01 compared to $0.08; Cash flow used in operations of ($1.0) million compared to $0.9 million provided by cash flow from operations; Debt as of March 31, 2024 of $19.1 million compared to $22.1 million as of March 31, 2023.EDGEWOOD, N.Y., May 15, 2024 (GLOBE NEWSWIRE) — CPI Aerostructures, Inc. (“CPI Aero” or the “Company”) (NYSE American: CVU) today announced financial results for the three month period ended March 31, 2024. “As anticipated, our first quarter 2024 revenue was 13% lower than first quarter 2023, driven primarily by the completion of deliveries...

First Quarter HighlightsRevenue of $258.8 million, down 5.4% year-over-year Gross margin of 22.0%, up 1.1% year-over-year Interest expense of $21.1M, down 52.3% year-over-year SG&A of $40.9M, down 7.9% year-over-year Operating profit of $0.1M versus a loss of $6.9 million year-over year Net loss of $25.6 million ($24.9 million attributable to Exela Technologies Inc), an improvement of $19.9 million year-over-year Adjusted EBITDA of $12.9M, down 11.1% year-over-yearIRVING, Texas, May 15, 2024 (GLOBE NEWSWIRE) — Exela Technologies, Inc. (“Exela” or the “Company”) (NASDAQ: XELA, XELAP), a global business process automation (“BPA”) leader, announced today its financial results for the first quarter 2024. “Our results show improvement across many operating metrics. We see benefits from increasing operating leverage and plan...

Increase in total revenues of 105% year-over-year 17% point increase in net margin, adjusted for stock option expense Cash and cash equivalents of $2.1 million as of April 1st, unchanged from December 31st, 2023LAS VEGAS, May 15, 2024 (GLOBE NEWSWIRE) — Jet.AI Inc. (the “Company”) (Nasdaq: JTAI), an innovative private aviation and artificial intelligence (“AI”) company, today announced financial results for the first quarter ended March 31, 2024. First Quarter 2024 and Recent Operational HighlightsReleased the National Jet Card Program using third party aircraft Announced partnership with FL3XX to integrate its DynoFlight carbon removal platform making it an easy option for thousands of FL3XX customers Launched Reroute AI, a web-based software tool designed to transform the way empty flight legs are utilized As previously...

Midland, Texas, May 15, 2024 (GLOBE NEWSWIRE) — Natural Gas Services Group, Inc. (“NGS” or the “Company”) (NYSE:NGS), a leading provider of natural gas compression equipment, technology and services to the energy industry, today announced financial results for the three months ended March 31, 2024. First Quarter 2024 HighlightsRental revenue of $33.7 million, an increase of 48% when compared to the first quarter of 2023 and 7% when compared to the fourth quarter of 2023. Net income of $5.1 million, or $0.41 per basic share, as compared to a net income of $0.4 million, or $0.03 per basic share in the first quarter of 2023 and net income of $1.7 million, or $0.14 per basic share in the fourth quarter of 2023. Adjusted EBITDA of $16.9 million, compared to $7.8 million in the first quarter of 2023 and $16.3 million in the fourth...

Reported Full Year 2023 total revenues of 2% growth at €48.5 million Secured approximately USD 20 million – strengthening cash position and expanding relationship with Lifera, a biopharma company owned by the PIF Positioned for strong performance in 2024, driven by new and existing Pharma business and solid Diagnostic growth in line with industry standards; guidance of FY2024 total revenue growth between 10-15% Ongoing strategic alternatives process focused on sustainable long-term value creation for the benefit of its stakeholdersCAMBRIDGE, Mass. and ROSTOCK, Germany and BERLIN, May 15, 2024 (GLOBE NEWSWIRE) — Centogene N.V. (Nasdaq: CNTG) (“we” or the “Company”), the essential life science partner for data-driven answers in rare and neurodegenerative diseases, today announced financial results for the fiscal year ended December...